Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1993 1
1996 1
1998 1
2005 1
2006 1
2008 1
2010 1
2011 1
2014 2
2015 1
2016 1
2018 2
2020 1
2021 1
2024 1
2025 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

16 results

Results by year

Filters applied: . Clear all
Page 1
Long-term safety and effectiveness of natalizumab treatment in clinical practice: 10 years of real-world data from the Tysabri Observational Program (TOP).
Butzkueven H, Kappos L, Wiendl H, Trojano M, Spelman T, Chang I, Kasliwal R, Jaitly S, Campbell N, Ho PR, Licata S; Tysabri Observational Program (TOP) Investigators. Butzkueven H, et al. J Neurol Neurosurg Psychiatry. 2020 Jun;91(6):660-668. doi: 10.1136/jnnp-2019-322326. Epub 2020 Mar 31. J Neurol Neurosurg Psychiatry. 2020. PMID: 32234967 Free PMC article.
[Drug-induced eosinophilic pneumonia].
Schelhorn J, Höfer L, Syrbe G, Polzer U. Schelhorn J, et al. Among authors: polzer u. Nervenarzt. 2008 Jun;79(6):696-8. doi: 10.1007/s00115-008-2437-y. Nervenarzt. 2008. PMID: 18324382 German.
Efficacy and safety of high-dose cabergoline in Parkinson's disease.
Odin P, Oehlwein C, Storch A, Polzer U, Werner G, Renner R, Shing M, Ludolph A, Schüler P. Odin P, et al. Among authors: polzer u. Acta Neurol Scand. 2006 Jan;113(1):18-24. doi: 10.1111/j.1600-0404.2005.00514.x. Acta Neurol Scand. 2006. PMID: 16367894 Clinical Trial.
Influence of the nonergot dopamine agonist piribedil on vigilance in patients With Parkinson Disease and excessive daytime sleepiness (PiViCog-PD): an 11-week randomized comparison trial against pramipexole and ropinirole.
Eggert K, Öhlwein C, Kassubek J, Wolz M, Kupsch A, Ceballos-Baumann A, Ehret R, Polzer U, Klostermann F, Schwarz J, Fuchs G, Jost W, Albert A, Haag A, Hermsen A, Lohmüller K, Kuhn K, Wangemann M, Oertel WH; In Cooperation With the German Competence Network on Parkinson’s Disease. Eggert K, et al. Among authors: polzer u. Clin Neuropharmacol. 2014 Jul-Aug;37(4):116-22. doi: 10.1097/WNF.0000000000000041. Clin Neuropharmacol. 2014. PMID: 24992083 Clinical Trial.
Prolonged-release oxycodone-naloxone for treatment of severe pain in patients with Parkinson's disease (PANDA): a double-blind, randomised, placebo-controlled trial.
Trenkwalder C, Chaudhuri KR, Martinez-Martin P, Rascol O, Ehret R, Vališ M, Sátori M, Krygowska-Wajs A, Marti MJ, Reimer K, Oksche A, Lomax M, DeCesare J, Hopp M; PANDA study group. Trenkwalder C, et al. Lancet Neurol. 2015 Dec;14(12):1161-70. doi: 10.1016/S1474-4422(15)00243-4. Epub 2015 Oct 19. Lancet Neurol. 2015. PMID: 26494524 Clinical Trial.
Facial affect recognition in the course of schizophrenia.
Wölwer W, Streit M, Polzer U, Gaebel W. Wölwer W, et al. Among authors: polzer u. Eur Arch Psychiatry Clin Neurosci. 1996;246(3):165-70. doi: 10.1007/BF02189118. Eur Arch Psychiatry Clin Neurosci. 1996. PMID: 8739402 Clinical Trial.
16 results